Product categoriesMedical Treatment

Products 1 to 10 of 33

Antibiotic - EV-035 by Emergent Biosolutions, Inc.
Biotech components: Bacteria
Business models: B2C
Country of production: USA
Country of distribution: USA + Switzerland
Intended consumer: Government
Date added: 2018/08/30 11:49 (12 months ago)
Date last modified: 2018/08/30 11:49 (12 months ago)
Known funding amount: 86,000,000 CHF
Funding types: Shareholder Investment
Industry: Health
Market status: Under Development
Organization type(s): Public Company
Product categories: Medical Treatment
Production process: Closed Production
Source: SynBio Database
Trading symbol: EVE (SWX)
Value chain stage: Finished Product
Biotech components: Virus
Business models: B2B
Country of production: USA
Country of distribution: N/A
Intended consumer: Commercial + Government
Date added: 2018/08/30 11:49 (12 months ago)
Date last modified: 2018/08/30 11:49 (12 months ago)
Known funding amount: 27,400,000 USD
Funding types: Research Institution
Industry: Health
Market status: Under Development
Organization type(s): University + Research Institution
Product categories: Medical Treatment
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Input
Biotech components: Virus
Business models: B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial + Government
Date added: 2018/08/30 11:49 (12 months ago)
Date last modified: 2018/08/30 11:49 (12 months ago)
Known funding amount: N/A
Funding types: Private Funding
Industry: Health
Market status: Under Development
Organization type(s): University + Research Institution
Product categories: Medical Treatment
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Finished Product
Biotech components: Gene Editing
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Research
Date added: 2018/08/30 11:49 (12 months ago)
Date last modified: 2018/09/28 16:57 (11 months ago)
Known funding amount: 250,000 USD
Funding types: Private Funding
Industry: Health
Market status: Under Development
Organization type(s): Private Company
Product categories: Medical Treatment
Production process: Closed Production
Source: NASEM Database
Trading symbol: N/A
Value chain stage: Input
Biotech components: Bacteria
Business models: B2B
Country of production: Norway
Country of distribution: N/A
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (12 months ago)
Date last modified: 2018/08/30 11:49 (12 months ago)
Known funding amount: N/A
Funding types: Venture Capital
Industry: Health
Market status: Under Development
Organization type(s): Private Company
Product categories: Medical Treatment
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Input
Biotech components: Gene Editing
Business models: B2C
Country of production: Switzerland
Country of distribution: Switzerland
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (12 months ago)
Date last modified: 2018/10/08 14:47 (11 months ago)
Known funding amount: N/A
Funding types: Government
Industry: Health
Market status: Early Stage Concept
Organization type(s): Research Institution + University
Product categories: Medical Treatment
Production process: Closed Production
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
DNA Nanorobots by Wyss Institute + Harvard University
Biotech components: Enzyme
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (12 months ago)
Date last modified: 2018/08/30 11:49 (12 months ago)
Known funding amount: 37,000,000 USD
Funding types: University + Government
Industry: Health
Market status: Early Stage Concept
Organization type(s): Private Company
Product categories: Medical Treatment
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Input
Biotech components: Bacteria
Business models: B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Government
Date added: 2018/08/30 11:49 (12 months ago)
Date last modified: 2019/08/20 15:56 (5 days ago)
Known funding amount: N/A
Funding types: Public Funding
Industry: Health
Market status: Under Development
Organization type(s): Government
Product categories: Medical Treatment
Production process: Open Release
Source: NASEM Database
Trading symbol: N/A
Value chain stage: Finished Product
Biotech components: Animal
Business models: B2B
Country of production: USA
Country of distribution: Brazil + USA + India + Panama + Cayman Islands
Intended consumer: Commercial + Government
Date added: 2018/08/30 11:49 (12 months ago)
Date last modified: 2018/08/30 11:49 (12 months ago)
Known funding amount: 26,132,305 GBP
Funding types: Private Funding
Industry: Health
Market status: Under Development
Organization type(s): Private Company
Product categories: Medical Treatment
Production process: Open Release
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Finished Product
EnLact Probiotics by ViThera Pharmaceuticals
Biotech components: Probiotic
Business models: B2C
Country of production: USA
Country of distribution: France + USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (12 months ago)
Date last modified: 2018/08/30 11:49 (12 months ago)
Known funding amount: N/A
Funding types: Private Funding
Industry: Health
Market status: Under Development
Organization type(s): Private Company
Product categories: Medical Treatment
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Finished Product